Free Trial

Aurora Cannabis Q3 2023 Earnings Report

Aurora Cannabis logo
C$5.28 -0.27 (-4.86%)
As of 01/31/2025 04:00 PM Eastern

Aurora Cannabis EPS Results

Actual EPS
-C$0.19
Consensus EPS
-C$0.05
Beat/Miss
Missed by -C$0.14
One Year Ago EPS
N/A

Aurora Cannabis Revenue Results

Actual Revenue
$64.03 million
Expected Revenue
$64.18 million
Beat/Miss
Missed by -$150.00 thousand
YoY Revenue Growth
N/A

Aurora Cannabis Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Aurora Cannabis Earnings Headlines

Aurora Cannabis announces corporate update
We recommended Palantir in 2021, now we're recommending this...
Simply put: All the grandiose claims you hear about AI will amount to nothing without one key investment. That's why I believe the biggest AI gains will NOT come from the "Next NVIDIA"... or some obscure AI startup you've never heard of. In fact, I'm convinced the biggest gains will come from one company that - at first glance - has nothing to do with AI at all. It's a Texas-based firm that provides the backbone for the entire $15.7 trillion AI industry.
Aurora Cannabis (ACB) Receives a Hold from ATB Capital Markets
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora Cannabis (TSE:ACB), headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

View Aurora Cannabis Profile

More Earnings Resources from MarketBeat